Clinical trials - Press Releases

Date	Title	Company
18-Sep-2020	Positive pivotal data for Libtayo® (cemiplimab) monotherapy in locally advanced basal cell carcinoma featured as a late-breaking presentation at ESMO	Regeneron Pharmaceuticals, Inc.
18-Sep-2020	UCB launches Community Health Fund to support vulnerable young people post-COVID-19 crisis	UCB
18-Sep-2020	Lynparza improved median time patients lived without disease progression to over four and half years in BRCA-mutated advanced ovarian cancer vs. just over one year with placebo	AstraZeneca
17-Sep-2020	PharmiWeb.Jobs Welcomes Northreach	Northreach
17-Sep-2020	2020 PM Society Digital Awards - Winners Announced	PM Society
17-Sep-2020	Cytel expands unique trial for early COVID-19 treatments in Global South	Cytel Inc.
17-Sep-2020	Huntington Study Group Announces a Partnership with Prilenia Therapeutics to Conduct a Global Phase 3 Clinical Study of Pridopidine in Huntington’s Disease	Huntington Study Group
16-Sep-2020	COVID-19 vaccine AZD1222 clinical trials resumed in the UK	AstraZeneca
15-Sep-2020	IDBS works with SCIEX to launch Analyst™ Software integration for enhanced regulatory compliance	IDBS
15-Sep-2020	AMRYT RECEIVES POSITIVE OPINION FROM EMA ON ORPHAN DRUG DESIGNATION FOR AP103	Amryt
15-Sep-2020	Live Event: Recent Austrian Corona Measures Validate New euroPLX Concept	RauCon
15-Sep-2020	Onyx Health Launches International PR Partnership with US Agency Jeff Winton Associates	Onyx Health
15-Sep-2020	SHIONOGI LAUNCHES FETCROJA® (CEFIDEROCOL) IN THE UNITED KINGDOM FOR THE TREATMENT OF INFECTIONS DUE TO AEROBIC GRAM-NEGATIVE BACTERIA IN ADULTS WITH LIMITED TREATMENT OPTIONS	Shionogi & Co., Ltd
15-Sep-2020	Royal Society of Chemistry’s journal archives now available to companies for Text and Data Mining	The Royal Society of Chemistry
15-Sep-2020	Novartis reports positive topline results from the first Phase III trial of Beovu® versus aflibercept in patients with diabetic macular edema (DME)	Novartis
15-Sep-2020	ISCT issues key findings and recommendations following 2020 Annual Meeting for cell and gene therapy industry	The International Society for Cell & Gene Therapy (ISCT)
15-Sep-2020	Neuraxpharm acquires market-leading value-added product for emergency treatment of epileptic children	Neuraxpharm
15-Sep-2020	Time for the adaptive profession – APM reveals findings of its Projecting the Future report	Association for Project Management (APM)
15-Sep-2020	The Net Zero Health Service	Ricardo
15-Sep-2020	Kiadis announces U.S. FDA approval of the Abigail Wexner Research Institute at Nationwide Children’s Hospital’s IND for a COVID-19 clinical trial with off-the-shelf K-NK cells using Kiadis’ proprietary platforms	Kiadis Pharma N.V.